[1]
D. V. Neves, C. P. Vieira, A. Rocha, and V. L. Lanchote, “Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model”, J Pharm Pharm Sci, vol. 21, no. 1, pp. 236–246, Jun. 2018.